secwatch / observer
8-K filed May 15, 2023, 7:59 PM ET ticker CRL CIK 0001100682
other confidence high sentiment neutral materiality 0.15

Charles River Labs annual meeting: directors elected, say-on-pay approved, PETA proposal defeated

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Advisory vote on executive compensation at the 2023-05-09 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-05-09
Exact text from the filing
The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers. For Against Abstain Broker Non-Votes 40,252,161 5,727,678 31,338 1,946,418
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent auditors at the 2023-05-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-09
Exact text from the filing
The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2023. For Against Abstain Broker Non-Votes 45,515,845 2,419,202 22,548 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Advisory vote on frequency of say-on-pay votes at the 2023-05-09 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-05-09
Exact text from the filing
The shareholders voted for one year with respect to the frequency with which shareholders are provided a non-binding, advisory vote on compensation paid to our named executive officers. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 45,471,178 10,778 515,767 13,454 1,946,418
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders approved Election of Directors at the 2023-05-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-09
Exact text from the filing
The following eleven (11) directors were elected to serve until our 2024 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below: Number of Shares Voted For Number of Shares Voted Against Number of Shares Abstained Broker Non-Votes James C. Foster 43,579,312 2,358,658 73,207 1,946,418 Nancy C. Andrews 44,650,631 1,341,754 18,792 1,946,418 Robert J. Bertolini 44,516,198 1,475,422 19,557 1,946,418 Deborah T. Kochevar 39,420,122 6,572,677 18,378 1,946,418 George Llado, Sr. 43,662,653 2,329,118 19,406 1,946,418 Martin W. Mackay 28,520,093 17,471,571 19,513 1,946,418 George E. Massaro 43,360,879 2,632,513 17,785 1,946,418 C. Richard Reese 43,199,915 2,793,600 17,662 1,946,418 Craig B. Thompson 45,551,367 440,372 19,438 1,946,418 Richard F. Wallman 43,370,869 2,394,188 246,120 1,946,418 Virginia M. Wilson 44,631,226 1,363,328 16,623 1,946,418
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. shareholders rejected Shareholder proposal to publish a report on non-human primates imported by the Company at the 2023-05-09 meeting.

Outcome
failed
Meeting
2023-05-09
Exact text from the filing
The shareholders did not approve the shareholder proposal submitted by PETA to publish a report on non-human primates imported by the Company. For Against Abstain Broker Non-Votes 16,382,651 29,395,105 233,421 1,946,418
View on SEC.gov

461 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR
accession 0001100682-23-000012
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.